The TAS Test project: a prospective longitudinal validation of new online motor-cognitive tests to detect preclinical Alzheimer’s disease and estimate 5-year risks of cognitive decline and dementia

BACKGROUND: The worldwide prevalence of dementia is rapidly rising. Alzheimer’s disease (AD), accounts for 70% of cases and has a 10–20-year preclinical period, when brain pathology covertly progresses before cognitive symptoms appear. The 2020 Lancet Commission estimates that 40% of dementia cases...

Descripción completa

Detalles Bibliográficos
Autores principales: Alty, Jane, Bai, Quan, Li, Renjie, Lawler, Katherine, St George, Rebecca J., Hill, Edward, Bindoff, Aidan, Garg, Saurabh, Wang, Xinyi, Huang, Guan, Zhang, Kaining, Rudd, Kaylee D., Bartlett, Larissa, Goldberg, Lynette R., Collins, Jessica M., Hinder, Mark R., Naismith, Sharon L., Hogg, David C., King, Anna E., Vickers, James C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9289357/
https://www.ncbi.nlm.nih.gov/pubmed/35850660
http://dx.doi.org/10.1186/s12883-022-02772-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9289357/
https://www.ncbi.nlm.nih.gov/pubmed/35850660
http://dx.doi.org/10.1186/s12883-022-02772-5

Ejemplares similares